Report
Jake Strole
EUR 100.00 For Business Accounts Only

Conmed's First-Quarter Results Meet Our Expectations; Shares Again Look Expensive

No-moat Conmed reported first-quarter results that largely met our expectations, and we don’t foresee many changes to our model that will push our $60 fair value estimate significantly in either direction. Segment revenue and non-GAAP profits were consistent with our view, although GAAP profitability and cash flow suffered from higher interest expense and additional costs associated with the ongoing integration of Buffalo Filter. Organic revenue growth clocked in at 6.3%, toward the high end of ...
Underlying
CONMED Corporation

CONMED is a medical technology company that provides surgical devices and equipment for minimally invasive procedures. The company's product lines consist of orthopedic surgery, which consists of sports medicine instrumentation and small bone, large bone and specialty powered surgical instruments, as well as imaging systems for use in minimally invasive surgery procedures and service fees related to the promotion and marketing of sports medicine allograft tissue; and general surgery, which consists of endo-mechanical instrumentation for minimally invasive laparoscopic and gastrointestinal procedures, cardiac monitoring products as well as electrosurgical generators and related instruments.

Provider
Morningstar
Morningstar

Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.

Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.

We have operations in 27 countries.

Analysts
Jake Strole

Other Reports on these Companies
Other Reports from Morningstar

ResearchPool Subscriptions

Get the most out of your insights

Get in touch